Arias et al. [101] indicated that aminophylline supplementation decreased glucose production with concomitant increased in insulin secretion, indicating aminophylline inhibits endogenous glucose production in type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.